Bausch Health Says Bausch + Lomb Subsidiary Sale Under Consideration

MT Newswires Live12-12

Bausch Health (BHC) said Thursday that it has authorized its Bausch + Lomb (BLCO) subsidiary to explore a potential sale, among the options under consideration to complete a previously announced plan to separate the two companies.

"The company believes that completing the full separation of its subsidiary, Bausch + Lomb Corporation makes strategic sense," Bausch said in a statement requested by the Canadian Investment Regulatory Organization. "That process is ongoing. No decision has been reached to proceed with any particular transaction, and there can be no assurance that it will result in a transaction."

Bausch Health, which trades on both the New York and Toronto stock exchanges, said it does not intend to provide additional detail unless necessary.

Bausch Health shares were 1.6% higher in US premarket trading.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2490800177?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-12 20:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2490800177","market":"sg","top_or_hot":-1,"title":"Bausch Health Says Bausch + Lomb Subsidiary Sale Under Consideration","media":"MT Newswires Live","content":"<html><body><p> Bausch Health (BHC) said Thursday that it has authorized its Bausch + Lomb (BLCO) subsidiary to explore a potential sale, among the options under consideration to complete a previously announced plan to separate the two companies.</p><p>\"The company believes that completing the full separation of its subsidiary, Bausch + Lomb Corporation makes strategic sense,\" Bausch said in a statement requested by the Canadian Investment Regulatory Organization. \"That process is ongoing. No decision has been reached to proceed with any particular transaction, and there can be no assurance that it will result in a transaction.\"</p><p>Bausch Health, which trades on both the New York and Toronto stock exchanges, said it does not intend to provide additional detail unless necessary.</p><p>Bausch Health shares were 1.6% higher in US premarket trading.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bausch Health Says Bausch + Lomb Subsidiary Sale Under Consideration</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBausch Health Says Bausch + Lomb Subsidiary Sale Under Consideration\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-12 20:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Bausch Health (BHC) said Thursday that it has authorized its Bausch + Lomb (BLCO) subsidiary to explore a potential sale, among the options under consideration to complete a previously announced plan ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BHC","symbol_name":"Bausch Health Companies Inc","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2490800177","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2490800177","pubTimestamp":1734007828,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Bausch Health  said Thursday that it has authorized its Bausch + Lomb  subsidiary to explore a potential sale, among the options under consideration to complete a previously announced plan to separate the two companies.\"The company believes that completing the full separation of its subsidiary, Bausch + Lomb Corporation makes strategic sense,\" Bausch said in a statement requested by the Canadian Investment Regulatory Organization. \"That process is ongoing. No decision has been reached to proceed with any particular transaction, and there can be no assurance that it will result in a transaction.\"Bausch Health, which trades on both the New York and Toronto stock exchanges, said it does not intend to provide additional detail unless necessary.Bausch Health shares were 1.6% higher in US premarket trading.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BHC":"Bausch Health Companies Inc","BLCO":"博士伦","BK4007":"制药","BK4198":"医疗保健用品"},"translate_title":"博士生健康表示正在考虑出售博士伦子公司","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BHC":0.9,"BLCO":0.9},"content_text":"Bausch Health (BHC) said Thursday that it has authorized its Bausch + Lomb (BLCO) subsidiary to explore a potential sale, among the options under consideration to complete a previously announced plan to separate the two companies.\"The company believes that completing the full separation of its subsidiary, Bausch + Lomb Corporation makes strategic sense,\" Bausch said in a statement requested by the Canadian Investment Regulatory Organization. \"That process is ongoing. No decision has been reached to proceed with any particular transaction, and there can be no assurance that it will result in a transaction.\"Bausch Health, which trades on both the New York and Toronto stock exchanges, said it does not intend to provide additional detail unless necessary.Bausch Health shares were 1.6% higher in US premarket trading.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2490800177"}